A good Night's sleep: a new weapon against teen borderline personality disorder?

NCT ID NCT04507308

Completed Symptom relief Sponsor: University of Utah Source: ClinicalTrials.gov ↗

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This study explores whether a single-session sleep training program can improve sleep and reduce symptoms of borderline personality disorder (BPD) in teenagers. Teens aged 13-18 with BPD symptoms will receive a brief intervention based on the TSC-Youth protocol, which teaches healthy sleep habits. Researchers will track sleep and BPD symptoms before and after the intervention to see if better sleep leads to fewer mood swings, less impulsivity, and improved overall functioning.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: A single-session behavioral sleep intervention based on the Transdiagnostic Sleep and Circadian Intervention (TSC-Youth) protocol, including psychoeducation and handouts.
What this could lead to: If effective, this brief sleep intervention could offer a low-cost, accessible way to improve sleep and reduce BPD symptoms in teens, potentially enhancing the success of other treatments.
What could go wrong: This is a small, early-stage study without a control group, so results may not be conclusive. The intervention is brief, and its effects on BPD symptoms may be limited or not lasting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BORDERLINE PERSONALITY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

borderline personality disorder Parasomnias sleep disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BORDERLINE PERSONALITY DISORDER SLEEP DISTURBANCE

Contacts and locations

Locations

University of Western Ontario Westminster Hall

London, Ontario, N6G 2M1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.